Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

Taurohyodeoxycholic acid sodium salt hydrate

Taurohyodeoxycholic acid sodium salt hydrate Structure
  • ₹11994.1 - ₹36047.25
  • Product name: Taurohyodeoxycholic acid sodium salt hydrate
  • CAS: 38411-85-7
  • MF: C26H46NNaO6S
  • MW: 523.7
  • EINECS:
  • MDL Number:MFCD00271496
  • Synonyms:Taurohyodeoxycholic acid sodium salt hydrate;Taurohyodeoxycholic acid hydrate sodium salt;Sodium taurohyodeoxycholate hydrate,Taurohyodeoxycholic acid sodium salt hydrate;5β-CHOLANIC ACID-3α, 6α-DIOL N-(2-SULPHOETHYL)-AMIDE
2 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)

Package

  • 250MG
  • 1G
  • ManufacturerSigma-Aldrich(India)
  • Product numberT0682
  • Product descriptionSodium taurohyodeoxycholate hydrate ≥98%
  • Packaging250MG
  • Price₹11994.1
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberT0682
  • Product descriptionSodium taurohyodeoxycholate hydrate ≥98%
  • Packaging1G
  • Price₹36047.25
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) T0682 Sodium taurohyodeoxycholate hydrate ≥98% 250MG ₹11994.1 2022-06-14 Buy
Sigma-Aldrich(India) T0682 Sodium taurohyodeoxycholate hydrate ≥98% 1G ₹36047.25 2022-06-14 Buy

Properties

storage temp. :Store at -20°C
solubility :DMF: 30 mg/ml,DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml,DMSO: 20 mg/ml,Ethanol: 20 mg/ml
form :A crystalline solid
color :White to off-white

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

Taurohyodeoxycholic acid (THDCA) is a taurine-conjugated form of the secondary bile acid hyodeoxycholic acid . THDCA decreases the size and weight of human gallstones in vitro. It increases bile flow, biliary cholesterol secretion, and biliary lipid secretion in rats. Co-administration of THDCA with taurochenodeoxycholic acid (TCDCA; ) prevents TCDCA-induced hepatotoxicity, increasing bile flow as well as biliary acid and phospholipid secretion in rats. THDCA also reduces myeloperoxidase activity, expression of TNF-α and IL-6, and colonic damage in a mouse model of TNBS-induced ulcerative colitis.

Related product price